Form 4: USANA Health Sciences Director John Turman Fleming Reports Stock Transaction
SEC Form 4
Director John Turman Fleming reports a transaction involving USANA Health Sciences Inc. stock.
Summary
- On May 2, 2025, Director John Turman Fleming engaged in a transaction involving USANA Health Sciences Inc. common stock.
- Fleming disposed of 674 shares of common stock.
- These shares were related to the vesting of restricted stock units.
- Following the transaction, Fleming still beneficially owns 4,700 shares.
- The transaction was executed pursuant to the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine stock transaction by a company director.
Industry Context
This is a routine disclosure related to insider transactions and is a normal part of corporate governance.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard insider transaction.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | 25% of Restricted Stock Units vest |
| 11/02/2024 | 25% of Restricted Stock Units vest |
| 02/02/2024 | 25% of Restricted Stock Units vest |
| 05/02/2024 | 25% of Restricted Stock Units vest |
| 05/02/2025 | Date of stock transaction |
| 05/06/2025 | Date of report filing |
Keywords
USANA Health Sciences, Director, Stock Transaction, Form 4, Fleming, USNA, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.